Table 2.
Correlation between DSG2 expression and clinicopathological features of early-stage CC
| Variables | Total | DSG2 expression | Pa | |
|---|---|---|---|---|
| Low | High | |||
| Age (years) | ||||
| ≤ 42 | 65 | 42 | 23 | 0.313 |
| > 42 | 85 | 48 | 37 | |
| FIGO stageb | ||||
| I | 132 | 87 | 45 | 0.187 |
| II | 18 | 9 | 9 | |
| Tumor size (cm) | ||||
| ≤ 4 | 125 | 85 | 40 | 0.022 |
| > 4 | 25 | 11 | 14 | |
| Pathologic types | ||||
| Squamous cell carcinoma | 128 | 82 | 46 | 0.205a |
| Adenocarcinoma | 18 | 13 | 5 | |
| Adenosquamous carcinoma | 4 | 1 | 3 | |
| Differentiation grade | ||||
| Well | 5 | 4 | 1 | 0.502a |
| Moderate | 69 | 45 | 24 | |
| Poor | 69 | 43 | 26 | |
| Stromal invasion | ||||
| < 1/2 | 87 | 58 | 29 | 0.424 |
| ≥ 1/2 | 63 | 38 | 25 | |
| Lymphovascular space invasion | ||||
| No | 134 | 89 | 45 | 0.074 |
| Yes | 16 | 7 | 9 | |
| Pelvic lymph node metastasis | ||||
| No | 120 | 89 | 31 | < 0.001 |
| Yes | 30 | 7 | 23 | |
| Vaginal involvement | ||||
| No | 148 | 94 | 54 | 0.408 |
| Yes | 2 | 2 | 0 | |
| Parametrial infiltration | ||||
| No | 149 | 95 | 54 | 0.64 |
| Yes | 1 | 1 | 0 | |
| Recurrence | ||||
| No | 126 | 89 | 37 | < 0.001 |
| Yes | 24 | 7 | 17 | |
| Vital status in 5 years | ||||
| Alive | 129 | 92 | 37 | < 0.001 |
| Dead | 21 | 4 | 17 | |
aP value from Fisher’s exact test; The italic number inside the table reflected P < 0.05
bFIGO 2009 was used